Dose Escalation Improves Cancer-Related Events at 10 Years for Intermediate- and High-Risk Prostate Cancer Patients Treated With Hypofractionated High-Dose-Rate Boost and External Beam Radiotherapy
2011 ◽
Vol 79
(2)
◽
pp. 363-370
◽
2015 ◽
Vol 93
(3)
◽
pp. E238-E239
2008 ◽
Vol 72
(1)
◽
pp. S307
2017 ◽
Vol 62
(2)
◽
pp. 256-261
◽
Keyword(s):